Auswirkungen der EU Clinical Trial Regulation (CTR) für die Schweiz
Crossref DOI link: https://doi.org/10.1007/s10304-020-00343-w
Published Online: 2020-10-04
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tschudin, S.
Text and Data Mining valid from 2020-10-01
Version of Record valid from 2020-10-01
Article History
First Online: 4 October 2020
Interessenkonflikt
: S. Tschudin gibt an, dass kein Interessenkonflikt besteht.
Free to read: This content has been made available to all.